AU2002364783A1 - Purified polypeptides involved in general metabolism - Google Patents

Purified polypeptides involved in general metabolism

Info

Publication number
AU2002364783A1
AU2002364783A1 AU2002364783A AU2002364783A AU2002364783A1 AU 2002364783 A1 AU2002364783 A1 AU 2002364783A1 AU 2002364783 A AU2002364783 A AU 2002364783A AU 2002364783 A AU2002364783 A AU 2002364783A AU 2002364783 A1 AU2002364783 A1 AU 2002364783A1
Authority
AU
Australia
Prior art keywords
purified polypeptides
polypeptides involved
general metabolism
metabolism
general
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002364783A
Other versions
AU2002364783A8 (en
Inventor
Muhammad Zahoor Alam
Donald Awrey
Bryan Beattie
Veronica Canadien
Akil Dharamsi
Megan Domagala
Aled Edwards
Simon Houston
Kamran Mansoury
Sasha Necakov
Kathleen Nethery
Ivy Ng
Benjamin Pinder
Bay Sheldrick
Francois Vallee
Masoud Vedadi
Olga Wrezel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affinium Pharmaceuticals Inc
Original Assignee
Affinium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affinium Pharmaceuticals Inc filed Critical Affinium Pharmaceuticals Inc
Publication of AU2002364783A1 publication Critical patent/AU2002364783A1/en
Publication of AU2002364783A8 publication Critical patent/AU2002364783A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002364783A 2001-11-21 2002-11-21 Purified polypeptides involved in general metabolism Abandoned AU2002364783A1 (en)

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
US33216001P 2001-11-21 2001-11-21
US60/332,160 2001-11-21
US33366101P 2001-11-27 2001-11-27
US33366501P 2001-11-27 2001-11-27
US60/333,665 2001-11-27
US60/333,661 2001-11-27
US34177001P 2001-12-18 2001-12-18
US60/341,770 2001-12-18
US34200301P 2001-12-19 2001-12-19
US34195401P 2001-12-19 2001-12-19
US60/342,003 2001-12-19
US60/341,954 2001-12-19
US34254201P 2001-12-20 2001-12-20
US60/342,542 2001-12-20
US34425201P 2001-12-21 2001-12-21
US60/344,252 2001-12-21
US34367901P 2001-12-28 2001-12-28
US34357001P 2001-12-28 2001-12-28
US34360601P 2001-12-28 2001-12-28
US60/343,606 2001-12-28
US60/343,679 2001-12-28
US60/343,570 2001-12-28
PCT/CA2002/001768 WO2003044185A2 (en) 2001-11-21 2002-11-21 Purified polypeptides involved in general metabolism

Publications (2)

Publication Number Publication Date
AU2002364783A1 true AU2002364783A1 (en) 2003-06-10
AU2002364783A8 AU2002364783A8 (en) 2003-06-10

Family

ID=27582776

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002364783A Abandoned AU2002364783A1 (en) 2001-11-21 2002-11-21 Purified polypeptides involved in general metabolism

Country Status (2)

Country Link
AU (1) AU2002364783A1 (en)
WO (1) WO2003044185A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2526651T3 (en) 2008-07-03 2015-01-14 Monsanto Technology Llc Combinations of derivatized saccharide surfactants and etheramine oxide surfactants as herbicide adjuvants
JP2013525271A (en) 2010-03-12 2013-06-20 チルドレンズ メディカル センター コーポレーション Immunogen and screening method thereof
WO2014124228A1 (en) 2013-02-07 2014-08-14 Children's Medical Center Corporation Protein antigens that provide protection against pneumococcal colonization and/or disease
WO2020056202A1 (en) 2018-09-12 2020-03-19 Affinivax, Inc. Multivalent pneumococcal vaccines
AU2022342080A1 (en) 2021-09-09 2024-03-28 Affinivax, Inc. Multivalent pneumococcal vaccines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037123A (en) * 1995-09-15 2000-03-14 Microcide Pharmaceuticals, Inc. Methods of screening for compounds active on Staphylococcus aureus target genes
AU7398900A (en) * 1999-09-23 2001-04-24 Hospital For Sick Children, The Three-dimensional structure and crystal of a class i alpha1,2-mannosidase, and methods of use thereof
WO2001062688A2 (en) * 2000-02-25 2001-08-30 Wyeth Methods of structure-based drug design using ms/nmr
CA2403200A1 (en) * 2000-03-28 2001-10-04 Wyeth Solution and crystal structures of zipa and zipa complex and uses thereof
WO2001079457A2 (en) * 2000-04-13 2001-10-25 University Health Network Crystal structure for rmlc and uses thereof
EP1158000A1 (en) * 2000-05-23 2001-11-28 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Crystal structure data of cystalysin and use thereof for the design and preparation of inhibitor molecules

Also Published As

Publication number Publication date
WO2003044185A3 (en) 2004-08-05
WO2003044185A2 (en) 2003-05-30
AU2002364783A8 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
GB0110544D0 (en) Improvements in substrates
AU2002343420A1 (en) Column line technology
AU2002343025A1 (en) Improvements in footwear
AU2002364783A1 (en) Purified polypeptides involved in general metabolism
AUPS198302A0 (en) Improvements in bowsprits
AU2002301358A1 (en) Improvements in Transmissometers
AU2002301354A1 (en) Improvements in Transmissometers
AU2002302851A1 (en) Atopy
AU2002328223A1 (en) Purified polypeptides involved in co-factor metabolism
AU2003281877A1 (en) Novel purified polypeptides involved in metabolism
AU2003213935A1 (en) Novel purified polypeptides involved in cellular metabolism
AU2003213933A1 (en) Purified polypeptides involved in protein synthesis and modification
AU2002328231A1 (en) Novel purified polypeptides involved in membrane biosynthesis
AU2002328224A1 (en) Purified polypeptides involved in membrane biosynthesis
AU2003213951A1 (en) Purified polypeptides involved in quorum sensing
AU2002364771A1 (en) Purified polypeptides involved in general metabolism as possible drug targets
AU2002364770A1 (en) Purified polypeptides involved in carbohydrate and coenzyme metabolism
AU2002343038A1 (en) Improvements in keyboards
AUPR516501A0 (en) Improvements in scooters
AUPR453501A0 (en) Improvements in decals
AU2003213953A1 (en) Novel purified polypeptides involved in nucleotide transport and metabolism
AUPR297201A0 (en) Transposable element expression in mammals
AU2002316873A1 (en) Architecture for providing services in the internet
AUPR533401A0 (en) Improvements in trolleys
AU2002301448A1 (en) Improvements in load-supporting structures

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase